Huge funding for cell rejuvenation but where is the data?
Posted by nof1317 in Longevity & Anti-Aging - 1 points, 0 comments.
This article talks about a company called NewLimit getting over 400 million dollars to work on rejuvenating old cells, basically focusing on liver disease. It sounds like a massive bet on cellular reprogramming to reverse aging.
As a physical therapist, I am always skeptical when I see these huge dollar amounts before the actual clinical data comes out. It feels like a lot of hype, and I want to see some peer reviewed citations before I get excited. My own experience with longevity stuff has been slow, and I usually prefer things with a proven track record.
Do you guys think this kind of funding actually speeds up the science, or is it just creating a bubble? I am curious if anyone here has read any of their early research or knows if this is just another venture capital play.
Community discussion - research and educational context only. Not medical advice.